Liew Z, et al. Dual therapy with PI/r+3TC or PI/r+TDF shows non-inferior HIV RNA suppression and lower rates of discontinuation for adverse events, versus triple therapy. Meta-analysis of seven randomised trials in 1635 patients. Abstract 0144. HIV/Drug Therapy Glasgow 2018.
First-in-human trial naar oraal vectorvaccin tegen hiv-1
dec 2018 | HIV, Vaccinatie, Virale infecties